References Honda, Yasushi, et al
In heart failure, expression of BCAA metabolic enzymes is regulated by transforming growth factor--activated kinase 1 (TAK1) and p38 MAPK signaling pathways, with downregulation of the transcription factor KLF15 leading to systemic decreased expression of BCAA metabolic enzymes (91)

Intended Use: For Laboratory Research Use Only Key Characteristics of Semaglutide (20 mg) Synthetic GLP-1 receptor agonist analog designed for controlled research Structural modifications improve resistance to rapid enzymatic breakdown in experimental models Fatty acid side-chain enhances receptor interaction duration in vitro High purity verified through HPLC and mass spectrometry Supplied as a lyophilized powder to maintain integrity before reconstitution Suitable for metabolic, endocrine, and receptor-signaling research Compatible with standard peptide preparation, dilution, and assay methods How Semaglutide (20 mg) Supports Research Semaglutide (20 mg) is widely used to study GLP-1 receptor-mediated signaling and related metabolic pathways
Different agents within this class have varying effects on gastric emptying and gastrointestinal tolerability
Frontline Gastroenterol 2023;14(6):5216
The added herb-lemon fragrance provides deep relaxation and helps destress